Evidence map›Paper›PMID 41526708›Full record

ReviewApplied microbiology and biotechnology2026

Alternative malonyl-CoA pathways for microbial production of diverse products.

Kian Ghaempanah, Hengrui Zhou, Sang Yup Lee

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Toward Complex Polyketide Biosynthesis inJournal of microbiology and biotechnology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kian GhaempanahDepartment of Chemical and Biomolecular Engineering (BK21 four), KAIST, Daejeon, 34141, Republic of Korea.ORCID http://orcid.org/0009-0002-4822-3804
Hengrui ZhouDepartment of Chemical and Biomolecular Engineering (BK21 four), KAIST, Daejeon, 34141, Republic of Korea.ORCID http://orcid.org/0000-0001-9555-3991
Sang Yup LeeDepartment of Chemical and Biomolecular Engineering (BK21 four), KAIST, Daejeon, 34141, Republic of Korea. leesy@kaist.ac.kr.ORCID http://orcid.org/0000-0003-0599-3091

Funding

Ministry of Science and ICT, South Korea RS-2025-02263193
6 · The paper itself

Abstract

Malonyl-CoA serves as a central precursor for the biosynthesis of diverse high-value compounds, including lipids, organic acids, and polyketides, in engineered microbial fermentation systems. However, insufficient malonyl-CoA supply often limits the production of these products. Intracellular malonyl-CoA levels are tightly regulated by the activities of acetyl-CoA carboxylase (ACC) and fatty acid synthesis pathway enzymes. Although strategies have been developed to redirect malonyl-CoA flux from fatty acid biosynthesis toward desired products, native ACC-mediated synthesis remains constrained by slow kinetics, complex regulation, and ATP consumption. To overcome these limitations, two alternative malonyl-CoA biosynthetic pathways have recently been developed. The malonate assimilation pathway enables direct uptake and CoA ligation of exogenous malonate, providing precise control over malonyl-CoA metabolism. The non-carboxylative malonyl-CoA (NCM) pathway converts pyruvate to malonyl-CoA through a novel intermediate, eliminating both ATP and CO

Indexed as

BacteriaBiosynthetic PathwaysMalonyl Coenzyme AMetabolic EngineeringAcetyl-CoA CarboxylaseAdenosine TriphosphateFatty AcidsFermentationMalonatesPyruvic AcidAcetyl-CoA CarboxylaseAdenosine TriphosphateFatty AcidsMalonatesmalonic acidMalonyl Coenzyme APyruvic AcidMalonate assimilationMalonyl-CoAMetabolic engineeringMicrobial cell factoriesNatural productNon-carboxylative malonyl-CoA pathway

Identifiers

PMID41526708
PMCPMC12799670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.